Showing results (131-140 of 418) with videos related to
Sort By:
Pageof 42
F1000Research|August 27, 2019
Biologic therapies for Crohn's disease: optimising the old and maximising the newMark Samaan, Samantha Campbell, Georgina Cunningham, et al.Gut|January 26, 2020
Regulatory T-cell therapy in Crohn's disease: challenges and advancesJennie N Clough, Omer S Omer, Scott Tasker, et al.United European Gastroenterology Journal|June 8, 2017
Cognitive impairment in Crohn's disease is associated with systemic inflammation, symptom burden and sleep disturbanceDaniel R van Langenberg, Greg W Yelland, Stephen R Robinson, et al.Inflammatory Bowel Diseases|September 11, 2007
Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colonCatherine Croagh, Susan J Shepherd, Melissa Berryman, et al.United European Gastroenterology Journal|January 17, 2026
The Associations of Sucrase-Isomaltase Hypomorphic Variants With Long-Term Outcomes and Dietary Intake in an Australian Irritable Bowel Syndrome Population Educated on the FODMAP Diet: A Cross-Sectional and Retrospective StudyHannah Silva, Tenghao Zheng, Judi Porter, et al.Alimentary Pharmacology & Therapeutics|June 28, 2021
Randomised clinical trial: adjunctive induction therapy with oral effervescent budesonide in newly diagnosed coeliac diseaseEvan D Newnham, Daniel Clayton-Chubb, Meena Nagarethinam, et al.Australasian Journal on Ageing|February 25, 2020
Initial experiences of an in-reach service providing iron infusions in residential aged care facilitiesHamed Zinsaz, Georgina Calder, Carmela Corallo, et al.Frontline Gastroenterology|August 26, 2017
Systemic mastocytosis: a gastroenterological perspectiveHamish Philpott, Paul Gow, Peter Crowley, et al.Alimentary Pharmacology & Therapeutics|June 22, 2021
Effect of point-of-care gastrointestinal ultrasound on decision-making and management in inflammatory bowel diseaseAntony B Friedman, Anil Asthana, Simon R Knowles, et al.Inflammatory Bowel Diseases|March 14, 2007
5-Aminosalicylic acid (mesalazine) use in Crohn's disease: a survey of the opinions and practice of Australian gastroenterologistsRichard B Gearry, Yousef Ajlouni, Sanjay Nandurkar, et al.Pageof 42